Cargando…

Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model

Murine leukemia virus (MLV) integrase (IN) lacking the C-terminal tail peptide (TP) loses its interaction with the host bromodomain and extraterminal (BET) proteins and displays decreased integration at promoter/enhancers and transcriptional start sites/CpG islands. MLV lacking the IN TP via an alte...

Descripción completa

Detalles Bibliográficos
Autores principales: Loyola, Lorenz, Achuthan, Vasudevan, Gilroy, Kathryn, Borland, Gillian, Kilbey, Anna, Mackay, Nancy, Bell, Margaret, Hay, Jodie, Aiyer, Sriram, Fingerman, Dylan, Villanueva, Rodrigo A., Cameron, Ewan, Kozak, Christine A., Engelman, Alan N., Neil, James, Roth, Monica J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974304/
https://www.ncbi.nlm.nih.gov/pubmed/31815961
http://dx.doi.org/10.1371/journal.ppat.1008154
_version_ 1783490072156307456
author Loyola, Lorenz
Achuthan, Vasudevan
Gilroy, Kathryn
Borland, Gillian
Kilbey, Anna
Mackay, Nancy
Bell, Margaret
Hay, Jodie
Aiyer, Sriram
Fingerman, Dylan
Villanueva, Rodrigo A.
Cameron, Ewan
Kozak, Christine A.
Engelman, Alan N.
Neil, James
Roth, Monica J.
author_facet Loyola, Lorenz
Achuthan, Vasudevan
Gilroy, Kathryn
Borland, Gillian
Kilbey, Anna
Mackay, Nancy
Bell, Margaret
Hay, Jodie
Aiyer, Sriram
Fingerman, Dylan
Villanueva, Rodrigo A.
Cameron, Ewan
Kozak, Christine A.
Engelman, Alan N.
Neil, James
Roth, Monica J.
author_sort Loyola, Lorenz
collection PubMed
description Murine leukemia virus (MLV) integrase (IN) lacking the C-terminal tail peptide (TP) loses its interaction with the host bromodomain and extraterminal (BET) proteins and displays decreased integration at promoter/enhancers and transcriptional start sites/CpG islands. MLV lacking the IN TP via an altered open reading frame was used to infect tumorigenesis mouse model (MYC/Runx2) animals to observe integration patterns and phenotypic effects, but viral passage resulted in the restoration of the IN TP through small deletions. Mice subsequently infected with an MLV IN lacking the TP coding sequence (TP(-)) showed an improved median survival by 15 days compared to wild type (WT) MLV infection. Recombination with polytropic endogenous retrovirus (ERV), Pmv20, was identified in seven mice displaying both fast and slow tumorigenesis, highlighting the strong selection within the mouse to maintain the full-length IN protein. Mapping the genomic locations of MLV in tumors from an infected mouse with no observed recombination with ERVs, TP(-)16, showed fewer integrations at TSS and CpG islands, compared to integrations observed in WT tumors. However, this mouse succumbed to the tumor in relatively rapid fashion (34 days). Analysis of the top copy number integrants in the TP(-)16 tumor revealed their proximity to known MLV common insertion site genes while maintaining the MLV IN TP(-) genotype. Furthermore, integration mapping in K562 cells revealed an insertion preference of MLV IN TP(-) within chromatin profile states associated with weakly transcribed heterochromatin with fewer integrations at histone marks associated with BET proteins (H3K4me1/2/3, and H3K27Ac). While MLV IN TP(-) showed a decreased overall rate of tumorigenesis compared to WT virus in the MYC/Runx2 model, MLV integration still occurred at regions associated with oncogenic driver genes independently from the influence of BET proteins, either stochastically or through trans-complementation by functional endogenous Gag-Pol protein.
format Online
Article
Text
id pubmed-6974304
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69743042020-02-04 Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model Loyola, Lorenz Achuthan, Vasudevan Gilroy, Kathryn Borland, Gillian Kilbey, Anna Mackay, Nancy Bell, Margaret Hay, Jodie Aiyer, Sriram Fingerman, Dylan Villanueva, Rodrigo A. Cameron, Ewan Kozak, Christine A. Engelman, Alan N. Neil, James Roth, Monica J. PLoS Pathog Research Article Murine leukemia virus (MLV) integrase (IN) lacking the C-terminal tail peptide (TP) loses its interaction with the host bromodomain and extraterminal (BET) proteins and displays decreased integration at promoter/enhancers and transcriptional start sites/CpG islands. MLV lacking the IN TP via an altered open reading frame was used to infect tumorigenesis mouse model (MYC/Runx2) animals to observe integration patterns and phenotypic effects, but viral passage resulted in the restoration of the IN TP through small deletions. Mice subsequently infected with an MLV IN lacking the TP coding sequence (TP(-)) showed an improved median survival by 15 days compared to wild type (WT) MLV infection. Recombination with polytropic endogenous retrovirus (ERV), Pmv20, was identified in seven mice displaying both fast and slow tumorigenesis, highlighting the strong selection within the mouse to maintain the full-length IN protein. Mapping the genomic locations of MLV in tumors from an infected mouse with no observed recombination with ERVs, TP(-)16, showed fewer integrations at TSS and CpG islands, compared to integrations observed in WT tumors. However, this mouse succumbed to the tumor in relatively rapid fashion (34 days). Analysis of the top copy number integrants in the TP(-)16 tumor revealed their proximity to known MLV common insertion site genes while maintaining the MLV IN TP(-) genotype. Furthermore, integration mapping in K562 cells revealed an insertion preference of MLV IN TP(-) within chromatin profile states associated with weakly transcribed heterochromatin with fewer integrations at histone marks associated with BET proteins (H3K4me1/2/3, and H3K27Ac). While MLV IN TP(-) showed a decreased overall rate of tumorigenesis compared to WT virus in the MYC/Runx2 model, MLV integration still occurred at regions associated with oncogenic driver genes independently from the influence of BET proteins, either stochastically or through trans-complementation by functional endogenous Gag-Pol protein. Public Library of Science 2019-12-09 /pmc/articles/PMC6974304/ /pubmed/31815961 http://dx.doi.org/10.1371/journal.ppat.1008154 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Loyola, Lorenz
Achuthan, Vasudevan
Gilroy, Kathryn
Borland, Gillian
Kilbey, Anna
Mackay, Nancy
Bell, Margaret
Hay, Jodie
Aiyer, Sriram
Fingerman, Dylan
Villanueva, Rodrigo A.
Cameron, Ewan
Kozak, Christine A.
Engelman, Alan N.
Neil, James
Roth, Monica J.
Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model
title Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model
title_full Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model
title_fullStr Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model
title_full_unstemmed Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model
title_short Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model
title_sort disrupting mlv integrase:bet protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a myc/runx2 mouse model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974304/
https://www.ncbi.nlm.nih.gov/pubmed/31815961
http://dx.doi.org/10.1371/journal.ppat.1008154
work_keys_str_mv AT loyolalorenz disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT achuthanvasudevan disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT gilroykathryn disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT borlandgillian disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT kilbeyanna disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT mackaynancy disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT bellmargaret disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT hayjodie disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT aiyersriram disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT fingermandylan disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT villanuevarodrigoa disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT cameronewan disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT kozakchristinea disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT engelmanalann disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT neiljames disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel
AT rothmonicaj disruptingmlvintegrasebetproteininteractionbiasesintegrationintoquiescentchromatinanddelaysbutdoesnoteliminatetumoractivationinamycrunx2mousemodel